Zaleplon (BioDeep_00000002677)
Secondary id: BioDeep_00000406063
human metabolite blood metabolite Chemicals and Drugs
代谢物信息卡片
N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide
化学式: C17H15N5O (305.1277)
中文名称: 扎莱普隆
谱图信息:
最多检出来源 Homo sapiens(urine) 31.72%
分子结构信息
SMILES: CCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C#N
InChI: InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3
描述信息
Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States.
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives
N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs
D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic
D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
同义名列表
11 个代谢物同义名
N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide; N-(3-{3-cyanopyrazolo[1,5-a]pyrimidin-7-yl}phenyl)-N-ethylacetamide; 3-(3-Cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-N-ethylacetanilide; 3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide; DEA no. 2781; Zelepion; zeleplon; Zaleplon; Starnoc; Sonata; Zaleplon
数据库引用编号
16 个数据库交叉引用编号
- ChEBI: CHEBI:10102
- KEGG: C07484
- KEGGdrug: D00530
- PubChem: 5719
- HMDB: HMDB0015097
- Metlin: METLIN85038
- DrugBank: DB00962
- ChEMBL: CHEMBL1521
- Wikipedia: Zaleplon
- chemspider: 5517
- CAS: 1007130-22-4
- CAS: 151319-34-5
- PMhub: MS000004459
- PubChem: 9687
- NIKKAJI: J575.185C
- KNApSAcK: 10102
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Sarah A Ali, Nabil A Alhakamy, Khaled M Hosny, Eman Alfayez, Deena M Bukhary, Awaji Y Safhi, Moutaz Y Badr, Rayan Y Mushtaq, Majed Alharbi, Bader Huwaimel, Mohammed Alissa, Sameer Alshehri, Ali H Alamri, Taha Alqahtani. Rapid oral transmucosal delivery of zaleplon-lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation.
Drug delivery.
2022 Dec; 29(1):2773-2783. doi:
10.1080/10717544.2022.2115165. [PMID: 36036168] - Jennifer R Goldschmied, Arjun Sengupta, Anup Sharma, Lynne Taylor, Knashawn H Morales, Michael E Thase, Michael E Thase, Aalim Weljie, Matthew S Kayser. Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression.
Psychopharmacology bulletin.
2021 06; 51(3):50-64. doi:
. [PMID: 34421144] - Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
Cell reports.
2021 04; 35(4):109040. doi:
10.1016/j.celrep.2021.109040. [PMID: 33910017] - Yusuf A Haggag, Ahmed Kh Abosalha, Murtaza M Tambuwala, Enass Y Osman, Sanaa A El-Gizawy, Ebtessam A Essa, Ahmed A Donia. Polymeric nanoencapsulation of zaleplon into PLGA nanoparticles for enhanced pharmacokinetics and pharmacological activity.
Biopharmaceutics & drug disposition.
2021 Jan; 42(1):12-23. doi:
10.1002/bdd.2255. [PMID: 33320969] - Wee Kiat Tan, Alyssa Rui Yi Tan, Punitha Sivanandam, Ernest Jing Hui Goh, Ze Ping Yap, Nur Fazilah Saburulla, Karl Austin-Muttitt, Jonathan G L Mullins, Aik Jiang Lau. In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate.
The Journal of pharmacology and experimental therapeutics.
2020 08; 374(2):295-307. doi:
10.1124/jpet.120.265249. [PMID: 32393528] - Keigo Nakayama, Hidetaka Kamimura, Hiroshi Suemizu, Nao Yoneda, Megumi Nishiwaki, Kazuhiko Iwamoto, Mari Mizunaga, Tamotsu Negoro, Soichiro Ito, Hiroshi Yamazaki, Yukihiro Nomura. Predicted values for human total clearance of a variety of typical compounds with differently humanized-liver mouse plasma data.
Drug metabolism and pharmacokinetics.
2020 Aug; 35(4):389-396. doi:
10.1016/j.dmpk.2020.05.004. [PMID: 32690433] - Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology.
2019 11; 96(5):629-640. doi:
10.1124/mol.119.115964. [PMID: 31515284] - Eman Abd-Elrasheed, Sara Nageeb El-Helaly, Manal M El-Ashmoony, Salwa Salah. Brain-targeted intranasal zaleplon solid dispersion in hydrophilic carrier system; 23 full-factorial design and in vivo determination of GABA neurotransmitter.
Drug development and industrial pharmacy.
2018 May; 44(5):741-749. doi:
10.1080/03639045.2017.1411941. [PMID: 29235903] - Rachel D Crouch, J Matthew Hutzler, J Scott Daniels. A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry.
Xenobiotica; the fate of foreign compounds in biological systems.
2018 Mar; 48(3):219-231. doi:
10.1080/00498254.2017.1296208. [PMID: 28281401] - Eman Abd-Elrasheed, Sara Nageeb El-Helaly, Manal M El-Ashmoony, Salwa Salah. Brain Targeted Intranasal Zaleplon Nano-emulsion: In-Vitro Characterization and Assessment of Gamma Aminobutyric Acid Levels in Rabbits' Brain and Plasma at Low and High Doses.
Current drug delivery.
2018; 15(6):898-906. doi:
10.2174/1567201814666171130121732. [PMID: 29189154] - Narendar Dudhipala, Karthik Yadav Janga. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
Drug development and industrial pharmacy.
2017 Jul; 43(7):1205-1214. doi:
10.1080/03639045.2017.1304957. [PMID: 28274147] - Chiaki Tanoue, Kazumi Sugihara, Yoshitaka Tayama, Naoto Uramaru, Yoko Watanabe, Shigeru Ohta, Shigeyuki Kitamura. Variability of Zaleplon 5-Oxidase Activity in Mice and Humans, and Inhibition by Raloxifene.
Drug metabolism letters.
2017; 10(4):278-285. doi:
10.2174/1872312810666161227145358. [PMID: 28029084] - Yong-zhi Zhang, Hong-yuan He, Cai-meng She, Jie Lian. [Research Progress on Forensic Toxicology of Z-drugs].
Fa yi xue za zhi.
2015 Aug; 31(4):293-7. doi:
. [PMID: 26665884] - ". Drugs for Insomnia.
The Medical letter on drugs and therapeutics.
2015 Jul; 57(1472):95-8. doi:
". [PMID: 26147892] - Deborah Montenarh, Markus Hopf, Hans H Maurer, Peter Schmidt, Andreas H Ewald. Detection and quantification of benzodiazepines and Z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte LC-MS/MS approach.
Analytical and bioanalytical chemistry.
2014 Jan; 406(3):803-18. doi:
10.1007/s00216-013-7513-x. [PMID: 24309624] - Chiaki Tanoue, Kazumi Sugihara, Naoto Uramaru, Yoshitaka Tayama, Yoko Watanabe, Toru Horie, Shigeru Ohta, Shigeyuki Kitamura. Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes.
Xenobiotica; the fate of foreign compounds in biological systems.
2013 Nov; 43(11):956-62. doi:
10.3109/00498254.2013.788232. [PMID: 23651075] - K Karthikeyan, Mahamad Yunnus A Mahat, S Chandrasekaran, K Gopal, P X Franklin, Balasubramanian Jaganatha Sivakumar, Gajendra Singh, Shridhar Narayanan, B Gopalan, Ansar A Khan. Bioanalytical method development, validation and quantification of dorsomorphin in rat plasma by LC-MS/MS.
Biomedical chromatography : BMC.
2013 Aug; 27(8):1018-26. doi:
10.1002/bmc.2899. [PMID: 23526253] - Naren Gunja. The clinical and forensic toxicology of Z-drugs.
Journal of medical toxicology : official journal of the American College of Medical Toxicology.
2013 Jun; 9(2):155-62. doi:
10.1007/s13181-013-0292-0. [PMID: 23404347] - Michael J Avram, Daniel A Spyker, John H Kehne, James V Cassella. The pharmacokinetics and pharmacodynamics of zaleplon delivered as a thermally generated aerosol in a single breath to volunteers.
Journal of clinical pharmacology.
2013 Feb; 53(2):140-50. doi:
10.1177/0091270012436886. [PMID: 23436259] - Ruth Verplaetse, Eva Cuypers, Jan Tytgat. The evaluation of the applicability of a high pH mobile phase in ultrahigh performance liquid chromatography tandem mass spectrometry analysis of benzodiazepines and benzodiazepine-like hypnotics in urine and blood.
Journal of chromatography. A.
2012 Aug; 1249(?):147-54. doi:
10.1016/j.chroma.2012.06.023. [PMID: 22749457] - David J Greenblatt, Jerold S Harmatz, James K Walsh, Rémy Luthringer, Luc Staner, Sarah Otmani, Jean-François Nedelec, Céline Francart, Sarah J Parent, Corinne Staner. Pharmacokinetic profile of SKP-1041, a modified release formulation of zaleplon.
Biopharmaceutics & drug disposition.
2011 Dec; 32(9):489-97. doi:
10.1002/bdd.773. [PMID: 21935965] - Susanna J Fenwick, James P Scarth. In vitro metabolism of tiletamine, zolazepam and nonbenzodiazepine sedatives: Identification of target metabolites for equine doping control.
Drug testing and analysis.
2011 Oct; 3(10):705-16. doi:
10.1002/dta.300. [PMID: 21916022] - Daniela Remane, Markus R Meyer, Dirk K Wissenbach, Hans H Maurer. Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs.
Analytical and bioanalytical chemistry.
2011 Sep; 401(4):1341-52. doi:
10.1007/s00216-011-5187-9. [PMID: 21773738] - Robert N Pechnick, Liliana M Lacayo, Charlene M Manalo, Yasmin Bholat, Inna Spivak. Eszopiclone stimulates the hypothalamo-pituitary-adrenal axis in the rat.
European journal of pharmacology.
2011 Jul; 661(1-3):22-6. doi:
10.1016/j.ejphar.2011.04.016. [PMID: 21540024] - Monique A J Mets, Edmund R Volkerts, Berend Olivier, Joris C Verster. Effect of hypnotic drugs on body balance and standing steadiness.
Sleep medicine reviews.
2010 Aug; 14(4):259-67. doi:
10.1016/j.smrv.2009.10.008. [PMID: 20171127] - Daniel T Anderson, Robert D Budd. Zaleplon (Sonata) analysis in postmortem specimens by gas chromatography-electron capture detection.
Journal of analytical toxicology.
2009 Oct; 33(8):481-5. doi:
10.1093/jat/33.8.481. [PMID: 19874656] - Kim Huynh, Guohong Wang, Christine Moore, Rehka Barhate, Cynthia Coulter, Warren Rodrigues, Philip Catbagan, James Soares. Development of a homogeneous immunoassay for the detection of zolpidem in urine.
Journal of analytical toxicology.
2009 Oct; 33(8):486-90. doi:
10.1093/jat/33.8.486. [PMID: 19874657] - Manthena V S Varma, Bo Feng, R Scott Obach, Matthew D Troutman, Jonathan Chupka, Howard R Miller, Ayman El-Kattan. Physicochemical determinants of human renal clearance.
Journal of medicinal chemistry.
2009 Aug; 52(15):4844-52. doi:
10.1021/jm900403j. [PMID: 19445515] - Charles G Knutson, Emily H Rubinson, Dapo Akingbade, Carolyn S Anderson, Donald F Stec, Katya V Petrova, Ivan D Kozekov, F Peter Guengerich, Carmelo J Rizzo, Lawrence J Marnett. Oxidation and glycolytic cleavage of etheno and propano DNA base adducts.
Biochemistry.
2009 Feb; 48(4):800-9. doi:
10.1021/bi801654j. [PMID: 19132922] - L Reidy, W Gennaro, B W Steele, H C Walls. The incidence of Zolpidem use in suspected DUI drivers in Miami-Dade Florida: a comparative study using immunalysis Zolpidem ELISA KIT and gas chromatography-mass spectrometry screening.
Journal of analytical toxicology.
2008 Oct; 32(8):688-94. doi:
10.1093/jat/32.8.688. [PMID: 19007522] - Clint Jean Louis, Bernabe Fernandez, Carlos Beaumont, Miguel Angel Pinillos, Anabel Bardom, Yolanda Encina. A case of zaleplon overdose.
Clinical toxicology (Philadelphia, Pa.).
2008 Sep; 46(8):782. doi:
10.1080/15563650701589417. [PMID: 19238743] - R Scott Obach, Franco Lombardo, Nigel J Waters. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Drug metabolism and disposition: the biological fate of chemicals.
2008 Jul; 36(7):1385-405. doi:
10.1124/dmd.108.020479. [PMID: 18426954] - Dmytro Berezhnoy, Maria C Gravielle, Scott Downing, Emmanuel Kostakis, Anthony S Basile, Phil Skolnick, Terrell T Gibbs, David H Farb. Pharmacological Properties of DOV 315,090, an ocinaplon metabolite.
BMC pharmacology.
2008 Jun; 8(?):11. doi:
10.1186/1471-2210-8-11. [PMID: 18554397] - Thomas Roth, David Mayleben, Bruce C Corser, Nikhilesh N Singh. Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.
Human psychopharmacology.
2008 Jan; 23(1):13-20. doi:
10.1002/hup.884. [PMID: 17907263] - Christian R Dolder, Michael H Nelson. Hypnosedative-induced complex behaviours : incidence, mechanisms and management.
CNS drugs.
2008; 22(12):1021-36. doi:
10.2165/0023210-200822120-00005. [PMID: 18998740] - Jaime M Monti, S R Pandi-Perumal. Eszopiclone: its use in the treatment of insomnia.
Neuropsychiatric disease and treatment.
2007 Aug; 3(4):441-53. doi:
NULL. [PMID: 19300573] - Shuangjin Cui, Fang Feng, Ming Ma, Han Liu, Yun Chen. Development and validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2007 Jul; 854(1-2):143-51. doi:
10.1016/j.jchromb.2007.04.019. [PMID: 17482898] - Georges M Gharabawi, Natalie C Gearhart, Robert A Lasser, Ramy A Mahmoud, Young Zhu, Erik Mannaert, Ineke Naessens, Cynthia A Bossie, Mary Kujawa, George M Simpson. Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval.
Annals of general psychiatry.
2007 Jan; 6(?):3. doi:
10.1186/1744-859x-6-3. [PMID: 17261186] - Ramakrishna V S Nirogi, Vishwottam N Kandikere, Koteshwara Mudigonda. Quantitation of zopiclone and desmethylzopiclone in human plasma by high-performance liquid chromatography using fluorescence detection.
Biomedical chromatography : BMC.
2006 Aug; 20(8):794-9. doi:
10.1002/bmc.601. [PMID: 16292747] - Robert E Petroski, Jordan E Pomeroy, Ronnie Das, Heath Bowman, Weidong Yang, Adele P Chen, Alan C Foster. Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptors.
The Journal of pharmacology and experimental therapeutics.
2006 Apr; 317(1):369-77. doi:
10.1124/jpet.105.096701. [PMID: 16399882] - Jadwiga Najib. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
Clinical therapeutics.
2006 Apr; 28(4):491-516. doi:
10.1016/j.clinthera.2006.04.014. [PMID: 16750462] - Beibei Zhang, Zunjian Zhang, Yuan Tian, Fengguo Xu, Yun Chen. High-performance liquid chromatography-atmospheric pressure chemical ionisation-mass spectrometry determination of zaleplon in human plasma.
Journal of pharmaceutical and biomedical analysis.
2006 Feb; 40(3):707-14. doi:
10.1016/j.jpba.2005.06.031. [PMID: 16087308] - Ramakrishna V S Nirogi, Vishwottam N Kandikere, Manoj Shukla, Koteshwara Mudigonda, Devender R Ajjala. Quantification of oxcarbazeipine and its active metabolite 10-hydroxycarbazepine in human plasma by high-performance liquid chromatography.
Arzneimittel-Forschung.
2006; 56(7):517-23. doi:
10.1055/s-0031-1296745. [PMID: 16927533] - Lijuan He, Fang Feng, Jie Wu. Determination of sertraline in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry and method validation.
Journal of chromatographic science.
2005 Nov; 43(10):532-5. doi:
10.1093/chromsci/43.10.532. [PMID: 16438795] - Helena K Nordgren, Per Holmgren, Paula Liljeberg, Nadja Eriksson, Olof Beck. Application of direct urine LC-MS-MS analysis for screening of novel substances in drug abusers.
Journal of analytical toxicology.
2005 May; 29(4):234-9. doi:
10.1093/jat/29.4.234. [PMID: 15975252] - N V S Ramakrishna, K N Vishwottam, S Wishu, M Koteshwara. Validated liquid chromatographic ultraviolet method for the quantitation of Etoricoxib in human plasma using liquid-liquid extraction.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2005 Feb; 816(1-2):215-21. doi:
10.1016/j.jchromb.2004.11.034. [PMID: 15664353] - Sonu Sundd Singh, Manish Jain, Hiten Shah, Sapna Gupta, Purav Thakker, Ruchy Shah, Braj Bhushan Lohray. Direct injection, column switching-liquid chromatographic technique for the estimation of rabeprazole in bioequivalence study.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2004 Dec; 813(1-2):247-54. doi:
10.1016/j.jchromb.2004.09.053. [PMID: 15556540] - Teemu Gunnar, Sirpa Mykkänen, Kari Ariniemi, Pirjo Lillsunde. Validated semiquantitative/quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2004 Jul; 806(2):205-19. doi:
10.1016/j.jchromb.2004.04.005. [PMID: 15171931] - David R Drover. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone.
Clinical pharmacokinetics.
2004; 43(4):227-38. doi:
10.2165/00003088-200443040-00002. [PMID: 15005637] - S G O'Brien, P Meinhardt, E Bond, J Beck, B Peng, C Dutreix, G Mehring, S Milosavljev, C Huber, R Capdeville, T Fischer. Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.
British journal of cancer.
2003 Nov; 89(10):1855-9. doi:
10.1038/sj.bjc.6601152. [PMID: 14612892] - Christian Horstkötter, Dirk Schepmann, Gottfried Blaschke. Separation and identification of zaleplon metabolites in human urine using capillary electrophoresis with laser-induced fluorescence detection and liquid chromatography-mass spectrometry.
Journal of chromatography. A.
2003 Oct; 1014(1-2):71-81. doi:
10.1016/s0021-9673(03)00564-8. [PMID: 14558613] - Hideaki Noguchi, Kazuhiro Kitazumi, Megumi Mori, Yoji Shiobara, Toshiharu Shiba. Effect of zaleplon, a non-benzodiazepine hypnotic, on melatonin secretion in rabbits.
Journal of pharmacological sciences.
2003 Oct; 93(2):204-9. doi:
10.1254/jphs.93.204. [PMID: 14578589] - Karla A Moore, Tasha L Zemrus, Vera Ramcharitar, Barry Levine, David R Fowler. Mixed drug intoxication involving zaleplon ('Sonata').
Forensic science international.
2003 Jul; 134(2-3):120-2. doi:
10.1016/s0379-0738(03)00130-0. [PMID: 12850405] - Heléne Salmonson, Jonas Höjer, Pierre Sundin. [In cases of coma and blue-green urine should overdosage of zaleplon be considered. First case reports].
Lakartidningen.
2003 Feb; 100(8):622-3. doi:
NULL. [PMID: 12640975] - Mario Giovanni Terzano, Mariano Rossi, Vincenzo Palomba, Arianna Smerieri, Liborio Parrino. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon.
Drug safety.
2003; 26(4):261-82. doi:
10.2165/00002018-200326040-00004. [PMID: 12608888] - Fang Feng, Juanjuan Jiang, Hui Dai, Jie Wu. Development and validation of a high-performance liquid chromatography-electrospray ionization-mass spectrometry assay for the determination of zaleplon in human plasma.
Journal of chromatographic science.
2003 Jan; 41(1):17-21. doi:
10.1093/chromsci/41.1.17. [PMID: 12597591] - Annemiek Vermeeren, Wim J Riedel, Martin P J van Boxtel, Mona Darwish, Isabelle Paty, Alain Patat. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol.
Sleep.
2002 Mar; 25(2):224-31. doi:
10.1093/sleep/25.2.224. [PMID: 11905433] - Jonas Höjer, Heléne Salmonson, Pierre Sundin. Zaleplon-induced coma and bluish-green urine: possible antidotal effect by flumazenil.
Journal of toxicology. Clinical toxicology.
2002; 40(5):571-2. doi:
10.1080/07313810.2002.11863667. [PMID: 12215053] - Alain Patat, Isabelle Paty, Ian Hindmarch. Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent.
Human psychopharmacology.
2001 Jul; 16(5):369-392. doi:
10.1002/hup.310. [PMID: 12404558] - R M Mangano. Efficacy and safety of zaleplon at peak plasma levels.
International journal of clinical practice. Supplement.
2001 Jan; ?(116):9-13. doi:
. [PMID: 11219331] - N A Ator, E M Weerts, B J Kaminski, M A Kautz, R R Griffiths. Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.
Drug and alcohol dependence.
2000 Dec; 61(1):69-84. doi:
10.1016/s0376-8716(00)00122-8. [PMID: 11064185] - N A Ator. Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons.
Drug and alcohol dependence.
2000 Dec; 61(1):55-68. doi:
10.1016/s0376-8716(00)00123-x. [PMID: 11064184] - P Sanchez Garcia, I Paty, C A Leister, P Guerra, J Frías, L E García Pérez, M Darwish. Effect of zaleplon on digoxin pharmacokinetics and pharmacodynamics.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
2000 Dec; 57(24):2267-70. doi:
10.1093/ajhp/57.24.2267. [PMID: 11146970] - P Sanchez Garcia, A Carcas, P Zapater, J Rosendo, I Paty, C A Leister, S M Troy. Absence of an interaction between ibuprofen and zaleplon.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
2000 Jun; 57(12):1137-41. doi:
10.1093/ajhp/57.12.1137. [PMID: 10911512] - W E Heydorn. Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.
Expert opinion on investigational drugs.
2000 Apr; 9(4):841-58. doi:
10.1517/13543784.9.4.841. [PMID: 11060714] - M Darwish, P T Martin, W H Cevallos, S Tse, S Wheeler, S M Troy. Rapid disappearance of zaleplon from breast milk after oral administration to lactating women.
Journal of clinical pharmacology.
1999 Jul; 39(7):670-4. doi:
10.1177/00912709922008308. [PMID: 10392321] - D J Greenblatt, J S Harmatz, L L von Moltke, B L Ehrenberg, L Harrel, K Corbett, M Counihan, J A Graf, M Darwish, P Mertzanis, P T Martin, W H Cevallos, R I Shader. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
Clinical pharmacology and therapeutics.
1998 Nov; 64(5):553-61. doi:
10.1016/s0009-9236(98)90139-4. [PMID: 9834048] - T Ohta. [Recent progress in development of psychotropic drugs (5)--Hypnotics].
Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology.
1996 Oct; 16(5):161-70. doi:
NULL. [PMID: 8962434] - J Gaudreault, F Varin, G M Pollack. Pharmacokinetics and anticonvulsant effect of a new hypnotic, CL 284,846, in rats.
Pharmaceutical research.
1995 Nov; 12(11):1592-7. doi:
10.1023/a:1016224629614. [PMID: 8592655] - B Beer, J R Ieni, W H Wu, D Clody, P Amorusi, J Rose, T Mant, J Gaudreault, A Cato, W Stern. A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic.
Journal of clinical pharmacology.
1994 Apr; 34(4):335-44. doi:
10.1002/j.1552-4604.1994.tb02002.x. [PMID: 8006201]
